Principle & Technology

  • Truenat (Molbio Diagnostics, India): An indigenously developed, chip-based, portable, battery-operated, real-time micro-PCR platform designed to deliver decentralized molecular diagnostics at primary health centers (PHCs) and community health centers (CHCs).
  • Global & National Recognition: Endorsed by WHO in 2020 as an upfront diagnostic test for tuberculosis and rifampicin resistance, and integrated by India's National Tuberculosis Elimination Program (NTEP) alongside CBNAAT (GeneXpert).
  • Platform Design: Replaces conventional laboratory thermal cyclers with disposable microchips containing freeze-dried, room-temperature-stable reagents ($2^\circ\text{C}\text{ to }30^\circ\text{C}$), eliminating the requirement for cold-chain storage and air-conditioned laboratories.

High-Yield Comparison: Truenat vs. GeneXpert (CBNAAT)

ParameterTruenat PlatformGeneXpert / CBNAAT
Origin & PlatformIndigenous (Molbio Diagnostics, Goa, India); micro-PCRMultinational (Cepheid, USA); closed cartridge PCR
Footprint & PortabilityHighly portable, lightweight ($<3\text{ kg}$); rechargeable battery-operated (up to 8 hours backup)Bulky benchtop instrument; mandates continuous uninterrupted AC mains / large UPS
Operating Ambient Temp$15^\circ\text{C}\text{ to }40^\circ\text{C}$; operates without air conditioningStrictly requires temperature-controlled room ($15^\circ\text{C}\text{ to }30^\circ\text{C}$)
Reagent StorageRoom temperature ($2^\circ\text{C}\text{ to }30^\circ\text{C}$); freeze-dried microchipsRoom temperature ($2^\circ\text{C}\text{ to }28^\circ\text{C}$), but cartridges are bulkier
Sample ProcessingStep 1: Automated extraction via Trueprep AUTO ($20\text{ min}$)
Step 2: Microchip PCR in Truelab analyzer ($35\text{ min}$)
Integrated all-in-one cartridge; hands-off sample-to-result ($120\text{ min}$)
Turnaround Time$\approx 55–60\text{ minutes}$ total per test$\approx 120\text{ minutes}$
Target Resistance Genes• MTB-RIF Dx: rpoB gene mutations
• MTB-INH Dx: katG and inhA promoter mutations
• Xpert Ultra: rpoB mutations (RIF)
• Xpert XDR: INH, FQ, BDQ, LZD

The Truenat Pediatric TB Workflow

flowchart TD
    A["Pediatric Presumptive TB Case<br>(Gastric aspirate, induced sputum, lymph node aspirate, CSF, or stool)"] --> B["<b>Trueprep AUTO V2 Extraction</b><br>Chemical lysis + magnetic bead nucleic acid purification (20 min)"]
    
    B --> C["<b>Truenat MTB / MTB Plus Chip PCR</b><br>Real-time micro-PCR thermal cycling (35 min)"]
    
    C --> D{"MTB Detected?"}
    D -->|"No (Negative)"| E["TB Unlikely<br>Investigate alternate etiologies; culture backup if high suspicion"]
    D -->|"Yes (Positive)"| F["<b>Reflex Test 1: Truenat MTB-RIF Dx</b><br>Detects <i>rpoB</i> gene mutations (Rifampicin resistance)"]
    
    F --> G{"Rifampicin Resistance?"}
    G -->|"RIF Resistant"| H["<b>MDR / RR-TB Confirmed</b><br>Refer for Second-Line LPA / BPaLM evaluation"]
    G -->|"RIF Sensitive"| I["<b>Reflex Test 2: Truenat MTB-INH Dx</b><br>Detects <i>katG</i> & <i>inhA</i> mutations (Isoniazid resistance)"]
    
    I --> J{"INH Resistance?"}
    J -->|"INH Sensitive"| K["Initiate 1st-line ATT (4-month non-severe or 6-month severe)"]
    J -->|"INH Resistant"| L["INH-Monoresistant TB Regimen (R-Z-E-Lfx)"]

Special Relevance In Pediatric Practice

  1. Paucibacillary Sensitivity (Truenat MTB Plus):
    • Children rarely produce sputum and harbor low bacillary loads; traditional Ziehl-Neelsen smear microscopy has an unacceptably low sensitivity ($<15–30\%$).
    • Truenat MTB Plus utilizes multi-copy targets (IS6110 and IS1081 insertion sequences), lowering the limit of detection to $<10–100\text{ CFU/mL}$, delivering $>85–90\%$ sensitivity against culture.
  2. Pediatric Specimen Versatility:
    • Validated for Gastric Aspirate / Lavage (GA), Induced Sputum (IS), and Bronchoalveolar Lavage (BAL).
    • Extrapulmonary Samples: Lymph node fine-needle aspirates (FNAC), pus, synovial fluid, and cerebrospinal fluid (CSF) for tuberculous meningitis.
    • Stool Testing: Novel stool processing methods (using OMNIgene-SPUTUM or simple centrifugation) enable non-invasive molecular confirmation in infants without requiring painful morning nasogastric tube insertions.
  3. Decentralized Same-Day "Test and Treat":
    • Because devices operate on batteries at primary health centers, rural infants can be sampled, diagnosed, and initiated on weight-appropriate dispersible ATT within the same clinical visit, eliminating the historical $30–50\%$ diagnostic default rate.

Expanded Diagnostic Menu Beyond Tuberculosis

The Truenat micro-PCR platform has expanded into multi-pathogen syndromic panels:

  • Vector-Borne Infections: Multiplex testing for Malaria (P. falciparum & P. vivax), Dengue, Chikungunya, Scrub Typhus (Orientia tsutsugamushi), and Leptospirosis.
  • Respiratory Pathogens: SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus (RSV).
  • Hepatitis: Viral load quantification for Hepatitis B (HBV DNA) and Hepatitis C (HCV RNA).